DIRS.INFO The most relevant business & tech news

A vial labelled "Novavax COVID-19 Vaccine" is seen in this illustration taken January 16, 2022. The Maryland-based company, whose COVID vaccine is its lone marketed product, has adopted cost-cutting measures and is counting on commercial sales of its updated shot to help it stay afloat. The CDC's Advisory Committee on Immunization Practices (ACIP) will not meet again to discuss the Novavax shot, a spokesperson said. Novavax's original COVID shot received U.S. authorization in July 2022, long after Pfizer and Moderna vaccines were in use. All three of the updated shots target the XBB.1.5 variant of the coronavirus.

Persons: Dado Ruvic, BioNTech, COVID, John Jacobs, Jacobs, Sriparna Roy, Bill Berkrot Organizations: REUTERS, U.S . Food, Drug Administration, U.S . Centers for Disease Control, Prevention, Pfizer Inc, Moderna, FDA, Pfizer, Moderna's, Thomson Locations: U.S, Maryland, Bengaluru

Coronavirus hospitalizations are on the decline in the U.S. as the omicron subvariant EG.5, or “eris,” continues to spread. New COVID-19 hospital admissions declined for the second week in a row, according to data from the Centers for Disease Control and Prevention. Eris is also the most prominent strain circulating globally, according to the World Health Organization. The organization recently updated its risk evaluation for the variant, finding that the public health risk posed by EG.5 is considered “low” at the global level. “While concurrent increases in the proportion of EG.5 and COVID-19 hospitalizations have been observed in some countries, no direct associations have been made between these hospitalizations and EG.5, and current hospitalizations are lower when compared to previous waves,” WHO said in the updated risk assessment.

Persons: Coronavirus, ”, Eris, Mandy Cohen, “, ” Cohen Organizations: omicron subvariant EG, Centers for Disease Control, EG, World Health Organization, WHO Locations: U.S, hospitalizations, COVID

☆ Australia's Qantas chairman says shareholders want him despite turmoil
▼ + stars: | 2023-09-27 | by ( ) www.reuters.com time to read: +3 min

REUTERS/Loren Elliott/File Photo/File Photo Acquire Licensing RightsSYDNEY, Sept 27 (Reuters) - The chairman of Australia's Qantas Airways (QAN.AX) on Wednesday vowed to stay in his role despite a host of scandals engulfing the airline, saying its biggest shareholders wanted leadership continuity even as its shares track a one-year low. "I've had meetings with our major shareholders two weeks ago, and they are very strongly supportive of me staying," Goyder told the hearing. "While I retain the confidence of shareholders and the board, I will continue to serve. But she and Goyder, the Qantas chairman since 2018, denied having any discussions about the Qatari request with any member of the federal government. Qatar Airways' senior vice-president of global sales, Matt Raos, told the hearing the company was "surprised and shocked" its application was denied without a reason given.

Persons: Loren Elliott, Richard Goyder, I've, Goyder, we've, isn't, Vanessa Hudson, Jayne Hrdlicka, Hrdlicka, Matt Raos, Byron Kaye, Gerry Doyle Organizations: Qantas, Sydney Airport, REUTERS, Rights, Qantas Airways, Stock, Qatar Airways, Virgin, Thomson Locations: Sydney, Australia, Virgin Australia, Qatar

☆ Qantas charter unit's pilots vote in favour of protected industrial action
▼ + stars: | 2023-09-26 | by ( ) www.reuters.com time to read: +2 min

Three pilot groups, including pilots from aircraft charter company Network Aviation, have been negotiating with Qantas management over wage policy revisions. A spokesperson for QantasLink, an airline brand of Qantas, termed the step towards industrial action by the AFAP as "disappointing". "We have already reached in-principle agreement with the two other unions representing Network Aviation pilots, and we're continuing to negotiate in good faith to secure new agreements with our turboprop pilots." There are contingency plans in place to minimise disruptions to customers if the union proceeds with the industrial action, the spokesperson told Reuters. The AFAP also flagged the potential industrial action might impact certain charter flight operations to large mines and oil gas projects in Western Australia.

Persons: Loren Elliott, Rishav Chatterjee, Lewis Jackson, Aishwarya Nair, Rashmi Organizations: Qantas, Sydney Airport, REUTERS, Pilots, Network Aviation, Qantas Airways, Australian Federation of Air Pilots, Reuters, Network Aviation's, Thomson Locations: Sydney, Australia, Western Australia

People walk by the Federal Reserve Bank of New York in the financial district of New York City, U.S., June 14, 2023. REUTERS/Shannon Stapleton//File Photo Acquire Licensing RightsCompanies Federal Reserve Bank of New York FollowNEW YORK, Sept 25 (Reuters) - A judge on Monday dismissed a lawsuit accusing the Federal Reserve Bank of New York of illegally firing two longtime employees who claimed religious objections in refusing to be vaccinated against COVID-19. The New York Fed began requiring COVID-19 vaccines for all employees in August 2021. The New York Fed declined to comment. The case is Gardner-Alfred et al v Federal Reserve Bank of New York, U.S. District Court, Southern District of New York, No.

Persons: Shannon Stapleton, District Judge Lewis Liman, Lori Gardner, Alfred, Jeanette Diaz, Gardner, Diaz, Liman, John Balestriere, Alfred et, Jonathan Stempel, Aurora Ellis Organizations: Federal Reserve Bank of New, REUTERS, Federal Reserve Bank of New York, COVID, U.S, District, New York Fed, Catholic, New, Fed, Court, Southern District of, Thomson Locations: Federal Reserve Bank of New York, New York City, U.S, Manhattan, Bronx , New York, Bayonne , New Jersey, New York, COVID, Southern District, Southern District of New York

Adding to its woes, last month the antitrust regulator sued Qantas accusing it of selling fares on thousands of already-cancelled flights in 2022. The so-called "flying kangaroo" said it would now spend A$80 million ($52 million) on "customer improvements" on top of the A$150 million previously flagged. "The group will continue to absorb these higher costs, but will monitor fuel prices in the weeks ahead and, if current levels are sustained, will look to adjust its settings," Qantas said. "Any changes would look to balance the recovery of higher costs with the importance of affordable travel in an environment where fares are already elevated." RBC Capital Markets analyst Owen Birrell said the company would likely absorb the higher fuel costs "until its target margins come under pressure and then would seek to claw back those costs through capacity cuts and higher fares.

Persons: Loren Elliott, Owen Birrell, Byron Kaye, Himanshi, Kim Coghill, Subhranshu Organizations: Qantas, Sydney Airport, REUTERS, Australia's, Qantas Airways, RBC Capital, Thomson Locations: Sydney, Australia, SYDNEY, Bengaluru

☆ Australia's Qantas flags hit from higher fuel prices
▼ + stars: | 2023-09-24 | by ( ) www.reuters.com time to read: +1 min

REUTERS/Loren Elliott/File Photo Acquire Licensing RightsSept 25 (Reuters) - Australia's Qantas Airways (QAN.AX) said on Monday higher fuel prices were expected to drive its fuel bill higher by about A$200 million ($128.80 million) in the first half of financial year 2024. "Fuel prices have increased by around 30% since May 2023, including a 10% spike since August. This is driven by a combination of higher oil prices, higher refiner margins and a lower Australian dollar," the carrier said in a statement. The company expects a further A$50 million impact due to non-fuel-related foreign exchange changes in the first half of the current fiscal year. Qantas said the customer-improvement initiative would be funded from its profit.

Persons: Loren Elliott, Himanshi, Kim Coghill, Subhranshu Organizations: Qantas, Sydney Airport, REUTERS, Australia's Qantas Airways, Thomson Locations: Sydney, Australia, Bengaluru

☆ Europe to decide on Novavax's COVID vaccine in October
▼ + stars: | 2023-09-21 | by ( ) www.reuters.com time to read: +1 min

Four vials with the "Nuvaxovid" COVID-19 vaccine from Novavax are pictured in Saabruecken, Germany, February 26, 2022. REUTERS/Frank Simon/File photo Acquire Licensing RightsSept 21 (Reuters) - The European Medicines Agency (EMA) expects to decide on the use of Novavax's (NVAX.O) updated COVID-19 vaccine in October, its director Emer Cooke said on Thursday. The agency had started the evaluation process for the protein-based shot on Aug. 24, Cooke said at a press conference. EU regulators recently gave the green light for an updated COVID-19 vaccine from Pfizer (PFE.N) and its German partner BioNTech (22UAy.DE), which targets the XBB.1.5 variant of Omicron. Moderna's (MRNA.O) updated shot is also on track to win approval.

Persons: Frank Simon, Emer Cooke, Cooke, BioNTech, Novavax, Bhanvi, Michael Erman, Saumyadeb Chakrabarty Organizations: REUTERS, European Medicines Agency, Pfizer, U.S . Food, Drug Administration, FDA, Moderna, Thomson Locations: Saabruecken, Germany, United States, Bengaluru, New York

☆ Instacart's biggest IPO twist: Tech trying to go public as a value stock
▼ + stars: | 2023-09-18 | by ( Tim Mullaney | ) www.cnbc.com time to read: +9 min

At the top of the latest IPO price range, the enterprise value would be 16x EBITDA. The right valuation for Instacart depends on where the ultimate rate of sales growth falls, Einhorn said. Including the cash on the company's balance sheet, that values Instacart at about three times EBITDA – way below DoorDash's valuation. Even that would value the company at only seven times 2025 EBITDA, and about 14 times EBITDA from the last four quarters, still a sharp discount to DoorDash. So in a twist few would have predicted in 2020 or 2021, Instacart is trying to go public as a value stock, carefully managed to wring the best results from potentially modest growth.

Persons: Instacart, –, Einhorn, Matt Einhorn, Mark Mahaney, DoorDash, Nicholas Cauley, Cauley, Covid, Nick Giovanni, Giovanni, EBITDA Organizations: Renaissance Capital, San Francisco, ISI, Walmart, Kroger, Aldi, Omicron, Gross Locations: DoorDash, EBITDA, York

☆ It's Time to Start Preparing Against Flu, RSV & COVID-19
▼ + stars: | 2023-09-15 | by ( Sept. | At A.M. | ) www.usnews.com time to read: +5 min

The flu vaccine is now available in some locations. And new respiratory syncytial virus (RSV) vaccines are recommended for some. "We should do what we can to protect ourselves — and others — with the best tool we have: the flu vaccine." Not only that, but COVID-19 and RSV could again spike at the same time as the flu, triggering a "tripledemic," Gandhi said. Women who are between 32 and 36 weeks pregnant can also protect their infants at birth by getting a new Pfizer RSV vaccine.

Persons: Cara Murez HealthDay, Soniya Gandhi, Gandhi, There's, Priya Soni, Sinai Guerin Children’s, Soni, Sonja Rosen, Rosen Organizations: Southern Hemisphere, U.S . Food, Drug Administration, Pfizer, GSK, U.S . Centers for Disease Control Locations: United States, Cedars, Sinai, Los Angeles, U.S, Guillain, Barre

The COVID-19 omicron subvariant EG.5 – unofficially nicknamed “eris” – was responsible for about 1 in 4 new coronavirus infections in recent weeks, according to data from the Centers for Disease Control and Prevention. It’s the highest prevalence for any coronavirus strain, though omicron subvariant FL.1.5.1 is quickly rising behind it, according to CDC data. While the variant scene continues to shift in the U.S., the CDC on Thursday released its respiratory disease season outlook for COVID-19, influenza and respiratory syncytial virus, or RSV. There is also a possibility that hospitalizations will surpass last year’s level and cause strain on health care facilities should a new coronavirus variant arise. COVID-19 by itself is unlikely to cause large waves of severe disease and hospitalizations because of widespread immunity to the coronavirus from prior infections, vaccinations or both, according to the CDC.

Persons: ” –, ” Organizations: subvariant EG, Centers for Disease Control, CDC Locations: U.S

The nationwide online poll, which concluded on Thursday, showed that almost 30% of respondents were very interested in getting the vaccine and another 24% were somewhat interested. U.S. public health officials earlier this week recommended updated COVID-19 vaccines from Pfizer (PFE.N)/BioNTech (22UAy.DE) and Moderna (MRNA.O) that target a recently circulating Omicron variant of the coronavirus. Almost 42% said they were mainly interested in getting the vaccine to reduce their risk of severe illness. During the last revaccination campaign, when most Americas had either already had the COVID virus or been previously vaccinated, only around 56.5 million people got the updated booster shots, CDC data shows. The Reuters/Ipsos poll was conducted online and nationwide between Sept. 8 and Sept. 14, gathering responses from 4,413 U.S. adults.

Persons: Adam Berman, Michelle Chester, Ron DeSantis, Jesse Goodman, Ahmed Aboulenein, Jason Lange, Michael Erman, Jennifer Rigby, Scott Malone, Leslie Adler Organizations: Jewish Medical Center, Northwell Health, Reuters, U.S . Centers for Disease Control, Pfizer, Moderna, Republicans, Republican, Wednesday, Georgetown University, U.S . Food, Drug Administration, Thomson Locations: Long, New Hyde Park , New York, WASHINGTON, United States, ., U.S, Americas, Washington, New York, London

☆ Stocks making the biggest moves midday: Citigroup, Adobe, Corteva and more
▼ + stars: | 2023-09-13 | by ( Pia Singh | ) www.cnbc.com time to read: +2 min

David Wadhwani, senior vice president of digital media for Adobe, speaks during the launch of Adobe Creative Cloud and CS6 in San Francisco, April 23, 2012. Redwire — The space infrastructure stock soared 5.6% Wednesday after Roth MKM initiated research coverage of the company with a buy rating. The firm said Redwire, which went public via a special purpose acquisition company in 2021, has "several billions worth of pipeline revenue opportunity." Citigroup — Shares advanced nearly 1.7% after the bank's CEO Jane Fraser announced a corporate reorganization Wednesday amid a stock slump. Adobe — Stock in the software company added about 2.1% in midday trading ahead of quarterly results Thursday.

Persons: David Wadhwani, Roth MKM, Jane Fraser, Nio, General Motors, —, Alex Harring, Hakyung Kim, Brian Evans, Samantha Subin, Tanaya Macheel Organizations: Adobe, Adobe Creative, Moderna —, Centers for Disease Control, Pfizer, Moderna, U.S . Food, Drug Administration, Citigroup —, Citigroup, Airline, American Airlines, Spirit Airlines, European Commission, Adobe —, FactSet, Traders, Ford Motor, General, UBS, Ford, General Motors Locations: San Francisco, U.S, Nio —, China

☆ New Covid boosters could reach Americans as soon as Thursday – here's what you need to know
▼ + stars: | 2023-09-13 | by ( Annika Kim Constantino | ) www.cnbc.com time to read: +9 min

Brian Cassella | Tribune News Service | Getty ImagesA new round of Covid vaccines is finally here in the U.S. Meanwhile, the FDA is still reviewing a third updated vaccine from Novavax for people ages 12 and up. Here's everything you need to know about the updated Covid vaccines, from where to find them, whether you can get them for free and when to get them. The agency's website outlines more specific guidelines for staying up to date on Covid vaccines, which differ depending on age group and risk level. Kroger Americans will soon be able to use the federal website vaccines.gov to find other locations offering the updated Covid shots, according to a CDC spokesperson.

Persons: Brian Cassella, Covid, Biden, Megan Wallace, they've, Brian Snyder, vaccines.gov, Evelyn Twentyman, Will, Moderna's, Twentyman, Taison Bell, Bell, CDC's Wallace, Wallace Organizations: Pfizer, Tribune, Service, U.S, The, Disease Control, Moderna, Food and Drug Administration, CDC, FDA, Walgreens, CNBC, WALGREENS, CVS Albertsons, Kroger, Manufacturers, CVS, University of Virginia Health, Younger Locations: Chatham , Illinois, U.S, Covid, Somerville , Massachusetts

☆ Fact Check-Trudeau post announcing ‘Digital Existence Act’ stems from parody
▼ + stars: | 2023-09-12 | by ( Reuters Fact Check | ) www.reuters.com time to read: +2 min

Canada’s Prime Minister Justin Trudeau did not post on social media platform X saying that his government was passing a “Digital Existence Act” due to the spread of a new coronavirus variant. That's why we're passing the “Digital Existence Act.”” (archive.ph/v621t)Confused users responded in the comments section saying: “Please explain how digital currency stops a virus,” and: “Is this real? Did he really tweet this.”The post is not visible on Trudeau’s official X account and there is no evidence that the alleged “Digital Existence Act” is real. The claim originates from the handle @Trudeaus_Ego, which describes its content as: “The egotistical thoughts of Prime Minister Trudeau” in its bio (twitter.com/Trudeaus_Ego). A screenshot shared online shows a parody post from an account impersonating Canadian Prime Minister Justin Trudeau announcing a “Digital Existence Act” due to a new variant of coronavirus.

Persons: Justin Trudeau, Trudeau, ”, Alison Murphy, Trudeau ”, Read Organizations: Canada’s, Twitter, Reuters, Omicron, Canadian Locations: Canada, Ottawa

The head of the Centers for Disease Control and Prevention signed off on a recommendation for updated COVID-19 vaccines for everyone over the age of 6 months, setting up the shots to become available later this week. “We have more tools than ever to prevent the worst outcomes from COVID-19,” CDC Director Mandy Cohen said in a statement. The Food and Drug Administration this week authorized the shots from Moderna and Pfizer that target the omicron subvariant XBB.1.5. An FDA official said during the meeting that “there is an urgent need for alternatives to mRNA based vaccines including gene based vaccines,” like the Novavax shot. The updated shots come as the U.S. sees its eighth straight week of rising coronavirus hospitalizations.

Persons: Mandy Cohen, ”, “ We're, ” Cohen Organizations: Centers for Disease Control, Prevention, CDC, Drug Administration, Moderna, Pfizer, FDA, EG, ” Health Locations: COVID, U.S

☆ CDC advisors recommend updated Covid vaccines for all Americans ages 6 months and up
▼ + stars: | 2023-09-12 | by ( Annika Kim Constantino | ) www.cnbc.com time to read: +3 min

An independent advisory panel to the Centers for Disease Control and Prevention on Tuesday recommended that all Americans ages 6 months and up receive updated Covid vaccines from Pfizer and Moderna , the next step toward the shots reaching Americans in the coming days. Thirteen advisors voted in favor of that "universal" recommendation for Americans, while one voted against it. It is a vaccine-preventable disease," said Dr. Beth Bell, clinical professor at the University of Washington and member of the panel, during the advisory meeting. "And so, for that reason, I favor the universal recommendation." The advisory panel's "universal" recommendation comes a day after the Food and Drug Administration approved the two mRNA jabs, which are designed to target the omicron subvariant XBB.1.5.

Persons: Mandy Cohen, Georgina Peacock, Beth Bell, Hospitalizations, hospitalizations, Megan Wallace Organizations: Moderna, Pharmacy, Centers for Disease Control, Pfizer, CDC, University of Washington, Food and Drug Administration, FDA Locations: Schwenksville , Pennsylvania, U.S

☆ Covid-19, flu, RSV: Here are the vaccine recommendations for fall—and the best time to get them
▼ + stars: | 2023-09-12 | by ( Renée Onque | ) www.cnbc.com time to read: +6 min

Updated Covid vaccinesOn Monday, the Food and Drug Administration approved the new Covid vaccine, which will target a variant of Omicron called XBB.1.5. When should you get your updated Covid vaccine? Older adults, and people with heart and lung disease, should also consider getting the RSV vaccine, says Pavia. "Because the ACIP gave a softer recommendation to the RSV vaccine, coverage is going to be variable," says Pavia. For those with certain Medicare plans, the RSV vaccine should be covered, specifically under a Part D plan.

Persons: there's, Andrew Pavia, It's, Don't, Biden, you've, they're, hasn't, it's Organizations: CNBC, Centers for Disease Control, University of Utah, Children's Hospital, CDC, Food and Drug Administration, COVID, FDA, CDC's, U.S . Department of Health, Human Services, Infants, The New York Times Locations: Pavia

The updated shots are part of a push by public health officials to align the next COVID vaccines more closely with the actual circulating variant of the virus, similar to the way annual flu shots are designed. The U.S. Food and Drug Administration (FDA) on Monday authorized updated COVID vaccines made by Pfizer (PFE.N) and its German partner BioNTech SE (22UAy.DE) as well as by Moderna (MRNA.O). CDC Director Mandy Cohen is expected to approve the recommendations issued by the advisers, allowing Americans to get the updated vaccines. The first COVID vaccines in 2020 were monovalent, or single-target vaccines, aimed at the original strain of the virus. They were followed by bivalent COVID vaccine booster shots that targeted both the original and the Omicron strains.

Persons: Emily Elconin, BioNTech, Caitlin Rivers, Mandy Cohen, Rivers, bivalent, Daniel Kuritzkes, Eris, Kuritzkes, Novavax, Bhanvi, Julie Steenhuysen, Will Dunham, Caroline Humer Organizations: REUTERS, U.S . Centers for Disease Control, Prevention, U.S . Food, Drug Administration, Pfizer, Moderna, FDA, Johns Hopkins Center for Health Security, CDC, Omicron, Brigham, Women's Hospital, Vaccine, EG, Thomson Locations: Waterford , Michigan, U.S, United States, Baltimore, Europe, Asia, Boston, Moderna, Bengaluru, Chicago

Most Americans should get an updated COVID-19 vaccine, health officials said Tuesday. Here is what you need to know about the new COVID-19 shots:WHO SHOULD GET THE UPDATED VACCINE? The agency's panel of outside exerts recommended the updated COVID-19 shots by a vote of 13-1. But federal officials said the new COVID-19 shots still will be free to most Americans through private insurance, Medicare or Medicaid. Similar to how flu shots are updated each year, the FDA gave COVID-19 vaccine makers a new recipe for this fall.

Persons: they’ve, ”, Camille Kotton, haven’t Organizations: Centers for Disease Control, CDC, TED, Drug Administration, Pfizer, Moderna, FDA, Massachusetts General Hospital, Associated Press Health, Science Department, Howard Hughes Medical Institute’s Science, Educational Media Group, AP Locations: U.S, Massachusetts, Novavax

☆ Air New Zealand sees 'significant' hit to flight schedule from RTX engine issue
▼ + stars: | 2023-09-11 | by ( Rajesh Kumar Singh | ) www.reuters.com time to read: +2 min

REUTERS/Loren Elliott(Reuters) -Air New Zealand on Tuesday warned that inspections of RTX’s Pratt & Whitney engines would have a “significant” impact on its flight schedule from next year. “This issue will further reduce engine availability and is expected to have a significant impact on the airline’s schedule from January 2024,” Air New Zealand said in a statement. Air New Zealand has 16 A320neo jets in its fleet of 106 aircraft, servicing Australia and the Pacific Island markets and, to a much lesser extent, the domestic market. Major customers that took delivery of affected A320neo jets include Spirit Airlines, JetBlue Airways, Hawaiian Airlines and Wizz Air, according to aviation data provider Cirium. Hungary’s Wizz Air, one of Europe’s largest lost-cost airlines, on Monday said its capacity could be reduced by 10% in the second half of 2024 as a result.

Persons: Loren Elliott, RTX’s Pratt, Greg Hayes Organizations: Air, Sydney Airport, REUTERS, Reuters, Zealand, Whitney, Airbus, ” Air, Air New, Pacific, Spirit Airlines, JetBlue Airways, Hawaiian Airlines, Wizz Locations: Zealand, Sydney, Australia, Air New Zealand

☆ What to Know About the New Covid Booster Shots
▼ + stars: | 2023-09-11 | by ( Knvul Sheikh | ) www.nytimes.com time to read: +2 min

How are the new Covid shots different from the last ones? Unlike the bivalent shots from last fall, the latest mRNA vaccines developed by Pfizer and Moderna are monovalent, meaning they are designed to protect against just one variant: XBB.1.5, a recent descendant of Omicron that emerged earlier this year. Vaccine makers Pfizer and Moderna have also announced that, according to their initial research, the new Covid vaccines provide good protection against both EG.5 and BA.2.86. The new shots do not include protection against the original virus, which may actually help broaden protection against new variants. “Our immune system, when we have seen something, is biased to seeing that again,” Dr. Ho said.

Persons: David Ho, “, ”, ” Dr, Ho Organizations: Pfizer, Moderna, Columbia University, Vaccine, EG, Regulators, XBB

☆ FDA approves updated Covid vaccines from Pfizer and Moderna as hospitalizations rise
▼ + stars: | 2023-09-11 | by ( Annika Kim Constantino | ) www.cnbc.com time to read: +3 min

The Food and Drug Administration on Monday approved updated Covid vaccines from Pfizer and Moderna , putting the shots on track to reach Americans within days as U.S. hospitalizations from the virus rise. The updated vaccines from Pfizer and Moderna won't be available to Americans just yet. The Biden administration said in August that it expects new single-strain vaccines from Pfizer, Moderna and Novavax targeting XBB.1.5 to be available to the public in mid-September. The upcoming arrival of updated vaccines offers some reassurance to Americans as the nation sees an increase in Covid cases and hospitalizations. Bourla and Moderna CEO Stéphane Bancel, in a separate statement, urged Americans to receive their updated Covid shot during the same appointment as their annual flu shot.

Persons: Biden, Pfizer's, Albert Bourla, Stéphane Bancel, hospitalizations Organizations: Pfizer, BioNTech, Peabody Institute Library, Drug Administration, Moderna, FDA, CDC, Covid, EG Locations: Peabody , Massachusetts, U.S

☆ US FDA authorizes Pfizer-BioNTech and Moderna's updated COVID shots
▼ + stars: | 2023-09-11 | by ( ) www.reuters.com time to read: +2 min

[1/3] Signage is seen outside of the Food and Drug Administration (FDA) headquarters in White Oak, Maryland, U.S., August 29, 2020. A third shot, made by Novavax (NVAX.O), is still under review by the FDA. But obviously that requires that FDA have decided the data supports it," said Jesse Goodman, a professor at Georgetown and former FDA chief scientist. Moderna and Pfizer, which is partnered with German biotech firm BioNTech SE (22UAy.DE), said the updated vaccines were expected to be available the United States in the coming days. An endorsement by CDC Director Mandy Cohen, expected shortly, should clear the way for the new shots.

Persons: Andrew Kelly, Novavax, Jesse Goodman, —, Mandy Cohen, Cohen, Sriparna Roy, Mariam Sunny, Michael Erman, Shinjini Organizations: Food and Drug Administration, FDA, REUTERS, Pfizer, Moderna, U.S . Food, Drug Administration, for Disease Control, Prevention, Georgetown, EG, CDC, Thomson Locations: White Oak , Maryland, U.S, United States, Bengaluru, New York

WASHINGTON (AP) — The U.S. approved updated COVID-19 vaccines Monday, hoping to rev up protection against the latest coronavirus strains and blunt any surge this fall and winter. It’s part of a shift to treat fall updates of the COVID-19 vaccine much like getting a yearly flu shot. A CDC advisory panel is set to issue recommendations Tuesday on who most needs the updated shots. The FDA pointedly isn’t calling this latest round a “booster” but instead a vaccine updated to better match the currently circulating virus. But while the FDA's decision allows for wide use of the updated shots, the CDC will decide how strongly different groups are urged to get them.

Persons: BioNTech, they’ve, There’s, Novavax, It’s, Peter Marks Organizations: WASHINGTON, Drug Administration, Moderna, Pfizer, Disease Control, CDC, FDA, Associated Press Health, Science Department, Howard Hughes Medical Institute’s Science, Educational Media Group, AP

Search resuls for: "Omicron"

25 mentions found